In the latest trading session,, 1.63 million BridgeBio Pharma Inc (NASDAQ:BBIO) shares changed hands as the company’s beta touched 1.16. With the company’s most recent
BridgeBio Pharma Inc (NASDAQ:BBIO) has a beta value of 1.13 and has seen 1.19 million shares traded in the recent trading session. The company, currently
BridgeBio Pharma Inc (NASDAQ:BBIO) has a beta value of 1.10 and has seen 0.71 million shares traded in the recent trading session. The company, currently
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne